Fig. 1 · Structure
Documents & Downloads
Evatanepag sodium
EP2 Receptor Agonist
Evatanepag sodium is a potent and selective agonist of the EP2 receptor, functioning as a non-prostanoid compound. This reagent has been shown to induce local bone formation in vivo, making it valuable for research into fractures and bone defects. Additionally, Evatanepag sodium is applicable in studies related to asthma, providing insights into its potential therapeutic effects in respiratory conditions.
In Stock
Free Aliquoting for Your Order
Tell us your preferred amount per vial. We’ll confirm the options.
Specifications
| Manufacturer | Adooq Bioscience |
|---|---|
| Actions | Agonist |
| CAS Number | 223490-49-1 |
| Applications | EP2 Receptor Agonist |
| Formula | C25H27N2NaO5S |
| Molecular Weight | 490.55 |
| Synonyms | CP 533536 |
| SMILES | O=C(O[Na])COC1=CC=CC(CN(CC2=CC=C(C(C)(C)C)C=C2)S(=O)(C3=CC=CN=C3)=O)=C1 |
Storage & Solubility
In Vitro Solubility
Reported Solubility
No reported solubility data are available for this product.
Preparing Stock Solutions
| Concentration | |
|---|---|
Values use four significant digits. Prepare to the final solution volume; this is not the volume of solvent to add.
Stock preparation is unavailable for this product molecular weight.
Calculated stock concentrations do not establish solvent solubility. Refer to the reported solubility data for experimental guidance.
Storage
Store powder at -20°C, keep desiccated.
In powder form, the chemical is stable for 36 months.
In solution, store at -20°C and use within 1 month to prevent loss of potency. Aliquot to avoid multiple freeze/thaw cycles.